Hydrocephalus Shunt Market - Product (Valves [Adjustable, Fixed], Catheters), Procedure (Ventriculoperitoneal, Lumboperitoneal, Ventriculoatrial, Ventriculopleural), Age Group (Pediatric, Adult), End Use (Hospitals, ASCs), Global Forecast (2024

Description

Hydrocephalus shunt market size is likely to register a 3.5% CAGR from 2024-2032 driven by the increasing prevalence of hydrocephalus and related neurological conditions. As per reports, annually around 400,000 children worldwide are diagnosed with hydrocephalus. The rising incidence of hydrocephalus, including both congenital and acquired forms, particularly in pediatric and elderly populations, is boosting the demand for shunt devices. Advances in diagnostic techniques and increased awareness among healthcare providers will also contribute to earlier detection and treatment.

Modern hydrocephalus shunts feature enhanced materials and advanced mechanisms for better bio-compatibility, reliability, and ease of use. Innovations, such as programmable valves and remote monitoring capabilities are also offering improved patient outcomes and convenience, making these devices more attractive to healthcare professionals. Increased R&D efforts aimed at refining shunt technologies and expanding applications will add to the market growth.

The industry is segmented into product, procedure type, age group, end-use, and region.

Based on product, the hydrocephalus shunt market from the hydrocephalus catheters segment will record a significant growth rate through 2032 due to their effectiveness and functionality. Advancements in catheter technology, such as improved materials and design innovations are also enhancing bio-compatibility and reducing the risk of complications, further contributing to their increasing adoption.

Hydrocephalus shunt market from the lumboperitoneal procedure type segment is poised to generate substantial revenue between 2024 and 2032 owing to their effectiveness in managing conditions where traditional ventriculoperitoneal shunts are less suitable. The ability of lumboperitoneal (LP) shunts to divert cerebrospinal fluid from the lumbar region to the peritoneal cavity provides an alternative approach to fluid management, making them a valuable option in complex cases.

Asia Pacific hydrocephalus shunt industry size will grow at a substantial CAGR through 2032 attributed to the rapidly improving healthcare infrastructure and increased investments in medical technologies. As several countries are enhancing their healthcare systems and expanding access to advanced treatments, there is greater availability of specialized care for hydrocephalus patients. Government initiatives and healthcare policies aimed at improving medical facilities and subsidizing treatment costs will also help in driving the regional market growth.

Product Code: 9350

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of congenital hydrocephalus
  - 3.2.1.2 Growing awareness towards surgical treatment of hydrocephalus
  - 3.2.1.3 Availability of reimbursement coverage for hydrocephalus treatments
  - 3.2.1.4 Increasing geriatric population
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Lack of infrastructure for performing complex neurosurgeries in emerging countries
  - 3.2.2.2 High cost associated to hydrocephalus shunt surgery and follow-up care
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Hydrocephalus valves
- 5.2.1 Adjustable pressure valves
- 5.2.2 Fixed pressure valves
5.3 Hydrocephalus catheters
- 5.3.1 Standard catheters
- 5.3.2 Antimicrobial catheters

Chapter 6 Market Estimates and Forecast, By Procedure type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Ventriculoperitoneal
6.3 Lumboperitoneal
6.4 Ventriculoatrial
6.5 Ventriculopleural

Chapter 7 Market Estimates and Forecast, By Age group, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pediatric
7.3 Adult

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Ambulatory surgery centers

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

10.1 B. Braun Melsungen AG
10.2 CHRISTOPH MIETHKE GMBH & CO. KG
10.3 DESU MEDIKAL A.S.
10.4 G. Surgiwear Ltd.
10.5 Hpbio
10.6 Integra LifeSciences Corporation
10.7 Kaneka Medix Corp.
10.8 Luciole Medical AG
10.9 Medtronic plc
10.10 Natus Medical Incorporated
10.11 SOPHYSA
10.12 TKB Corporation

Hydrocephalus Shunt Market - Product (Valves [Adjustable, Fixed], Catheters), Procedure (Ventriculoperitoneal, Lumboperitoneal, Ventriculoatrial, Ventriculopleural), Age Group (Pediatric, Adult), End Use (Hospitals, ASCs), Global Forecast (2024 - 2032)